Using the Right Cell for the Right Application: Expanding the Role of Transient Transfection
25 September 2015
Pharmaceutical, biopharmaceutical, and biotechnology companies must efficiently identify, develop, and quickly bring to market candidates -whether small molecule drugs, therapeutic proteins, or vaccines -with the highest level of efficacy at the lowest cost. There is no single, ideal cellular system with native physiology that provides a cost-and time-efficient means of fulfilling all aspects biotherapeutic and drug development. Therefore, scientists must identify what they deem as the ‘right cell’ for the right application. This poster provides project-specific data generated with the MaxCyte STX® Scalable Transfection System using the most appropriate cell line for a given application, for example primary neurons for Alzheimer’s research or human-derided cells for cystic fibrosis drug development.